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Abstract
Background: This paper presents Part 2 of a literature review examining medication safety in the
Australian acute care setting. This review was undertaken for the Australian Commission on Safety
and Quality in Health Care, updating the 2002 national report on medication safety. Part 2 of the
review examined the Australian evidence base for approaches to build safer medication systems in
acute care.
Methods: A literature search was conducted to identify Australian studies and programs published
from 2002 to 2008 which examined strategies and activities for improving medication safety in
acute care.
Results and conclusion: Since 2002 there has been significant progress in strategies to improve
prescription writing in hospitals with the introduction of a National Inpatient Medication Chart.
There are also systems in place to ensure a nationally coordinated approach to the ongoing
optimisation of the chart. Progress has been made with Australian research examining the
implementation of computerised prescribing systems with clinical decision support. These studies
have highlighted barriers and facilitators to the introduction of such systems that can inform wider
implementation. However, Australian studies assessing outcomes of this strategy on medication
incidents or patient outcomes are still lacking. In studies assessing education for reducing
medication errors, academic detailing has been demonstrated to reduce errors in prescriptions for
Schedule 8 medicines and a program was shown to be effective in reducing error prone prescribing
abbreviations. Published studies continue to support the role of clinical pharmacist services in
improving medication safety. Studies on strategies to improve communication between different
care settings, such as liaison pharmacist services, have focussed on implementation issues now that
funding is available for community-based services. Double checking versus single-checking by
nurses and patient self-administration in hospital has been assessed in small studies. No new studies
were located assessing the impact of individual patient medication supply, adverse drug event alerts
or bar coding. There is still limited research assessing the impact of an integrated systems approach
on medication safety in Australian acute care.
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Background
This paper is the second in a two-part literature review of
medication safety in the Australian acute care setting [1].
It examines the Australian evidence-base for strategies to
reduce medication errors and updates the data presented
in the Second National Report on Patient Safety - Improving
Medication Safety [2].
International evidence has identified a number of tools or
practices that may reduce medication incidents in health-
care. Computerised physician order entry (CPOE) cou-
pled with clinical decision support systems (CDSS) is
amongst the most studied. These systems allow standard-
ised online prescribing coupled to computerised advice to
support prescribing decisions. The systems may provide
automated checks or alerts such as drug-drug interaction
checking or drug allergy alerts. These systems can reduce
adverse drug events in hospital settings [3] although there
have been reports of increased error rates when imple-
mentation problems have occurred [4]. Most studies have
examined "home-grown" CPOE/CDSS systems developed
and used within an institution; commercially developed
systems have been less well studied [3].
International studies also support the role of clinical phar-
macists in hospital wards for preventing adverse drug
events [4-6]. Other strategies examined for improving
medication safety in acute care include individual patient
supply of medication, robotic systems for medication dis-
pensing (including automated bedside systems), bar cod-
ing of medication packaging and patients, intravenous
devices capable of performing dilutions, computerised
medication records, changes to systems to facilitate
improved communication and educational interventions
[4,7,8].
This review examines the published literature on the evi-
dence and implementation of these strategies in the Aus-
tralian acute care setting. While these approaches may
impact particular stages in the medication use process
(such as prescribing, transcribing of information, dispens-
ing, administration), no single strategy can target all
stages of the complex process. While the evidence for
these strategies has been reviewed separately the impor-
tance of using a multifaceted approach, incorporating a
number of these strategies, is emphasised to improve
medication safety.
The analysis of medication incident reports occurring
within an institution can allow problems with systems to
be identified and corrected. "Root cause analysis" is one
technique which has been adapted from industries such as
aviation and aerospace for use in the health care setting
[9]. This involves identifying the "root" and contributory
factors that have led to a medication incident rather than
seeking to blame the individual/s involved. This informa-
tion can be used to formulate strategies to prevent similar
incidents, which in turn can be evaluated as part of a con-
tinuous quality improvement cycle [10]. In this review,
root cause analysis strategies were included, as were sys-
tems to improve the reporting of medication incidents in
acute care.
Methods
Search strategy
Databases and search terms used in the search strategy
have been detailed in Part 1 of the review [1]. Criteria rel-
evant to the general headings in the Second National Report
on Patient Safety - Improving Medication Safety [2] were
used.
The database search was supplemented with review of rel-
evant reports and resources on the Australian Commis-
sion on Safety and Quality in Health Care website http://
www.safetyandquality.gov.au/. Additionally, the website
of the Australian Government Department Health and
Ageing was searched for information and publications
relating to government electronic health initiatives
including bar coding, shared electronic medical records
and electronic prescribing. State government websites and
the website of the New South Wales Therapeutic Advisory
Group (NSW TAG) were searched for information on
medication safety initiatives in hospitals.
Selection of studies for review
Letters, study reports and reviews published between
2002 and 2008 were selected if they reported on:
- systems to promote improved prescription writing;
- systems to promote dissemination of information about
medicines and improved prescriber decision-making;
- systems used to promote accurate dispensing and/or dis-
tribution of medicines;
- systems to ensure adequate checking;
- systems used to promote accurate administration of
medicines;
- systems to improve management of medicines;
- medicine-specific handling/management strategies;
- clinical pharmacy services;
- systems to improve information transfer about medi-
cines between hospital and community settings;Australia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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- medication management services and case conferencing;
- systems-based approaches to understanding and pre-
venting medication errors;
- systems to promote reporting of medication incidents
and adverse drug reactions in hospitals.
Studies undertaken in the community setting were
excluded.
Results and Discussion
Evidence for systems to improve prescription writing
The National Inpatient Medication Chart
A National Inpatient Medication Chart (NIMC) aims to
improve medication safety through standardisation of
medication ordering in all Australian public hospitals,
and a number of private hospitals. The NIMC was
adopted for national roll-out following an agreement of
the Australian Health Ministers Council in 2004 [11]. The
recommendation for a process of pharmaceutical review
of all aspects of medication management in the hospital
was also part of this reform [12].
The chart along with education on safe prescribing and
administration were piloted in 31 public and private hos-
pitals in metropolitan, regional and rural areas in 2004
[13]. Pre and post-implementation audits were under-
taken by 28 sites. Improvements seen in the combined
results included:
- increased documentation of adverse drug reactions
(21% at baseline to 50% at three months);
- decreased prescription of drugs to which patient had
an allergy (9% to 6%);
- increased entry of actual administration times (18%
to 68%);
- increased frequency of providing the indication for a
'prn' (as needed) medication (13% to 26%);
- increased documentation of the maximum dose for a
'prn' medication (24% to 36%);
- increased frequency of the prescriber name being
identifiable (41% to 79%); and
- increased frequency of target international normal-
ised ratio (INR) documentation (9% to 71%) [13].
The study used surrogate, rather than direct, measures of
patient harm [13].
An implementation strategy for the NIMC in three Victo-
rian hospitals involved an interdisciplinary steering group
to support integration across the whole organization, a
dedicated project officer acting as facilitator and coordina-
tor and four interdisciplinary working groups addressing
supply, communication, education and evaluation issues
[14].
An audit of the NIMC design and performance was also
undertaken at the Royal Perth Hospital (RPH) [15]. Chart
design assessment was performed on 15 design features
and compared with the previously used RPH chart, four
other WA hospital charts and nine charts from teaching
hospitals in other states and territories. Completion of the
individual fields of the chart was assessed and an audit of
NIMC charts from six medical and surgical wards of the
hospital was compared to completion of the previous
RPH chart. Aspects of the design of the NICM considered
likely to improve medication safety included a) a section
to complete medication history; b) provision for record-
ing sustained-release dose forms; c) a mechanism to circle
inpatient drugs intended for provision at discharge; d)
provision for documenting a medicine's indication; and
e) direction to record intended administration times of
each medicine. Four of these five advantages were poorly
complied with in practice. Overall compliance with the
NIMC was 56% [95% CI 43-67%]. Only 2.3% of charts
had the medication history completed. There was a mod-
est, but non-significant increase in overall compliance
after the introduction of the NIMC compared to the previ-
ous chart (6% [95% CI -0.2 to 13%]). Concerns about
design features of the chart included cramped design, lack
of colour, lack of provision for variable dosing and the
need for, on average, twice as many charts per admission
(and hence increased requirements for rewriting charts
and possible transcription errors) [15].
Tools have been developed to allow ongoing evaluation
of the chart [16]. Currently local management of the
NIMC is overseen by local jurisdictional bodies at the
State and Territory level [17]. Where relevant, the local
body will refer proposed changes to the national NIMC
Oversight Committee. Versions of the NIMC for paediat-
ric patients and patients requiring long hospital stays are
available [18,19].
Prescriber education
Education services to individual healthcare professionals
are sometimes referred to as 'academic detailing'. This
term refers to an educational approach based on princi-
ples of communications theory and behaviour change
[20].
A 2001 NSW study examined whether academic detailing
could reduce prescription errors for drugs of addictionAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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(DOA) in the hospital setting [21]. Errors assessed
included:
- the quantity not written in both words and numbers;
- the DOA not written on a separate script;
- alterations to the script not initialled;
- details of the preparation or form of the drug omit-
ted;
- liquid preparations without a milligram dose given;
- strength omitted or incorrect.
The intervention involved a one-on-one academic detail-
ing session for all first and second year post-graduate prac-
titioners. A follow-up session was conducted after two
months. Error rates were assessed two months after the
intervention and compared with a control hospital. The
baseline levels of errors at the intervention hospital
(approximately 40%) were higher than those of the con-
trol hospital (25%), making comparison difficult. Error
rates reduced from 41% of 46 prescriptions pre-interven-
tion to 24% of 128 prescriptions post-intervention (p <
0.001, chi square = 17.3). There was no change in the
error rate at the control hospital. No assessment was made
on the likely to impact of these errors on patient out-
comes.
Further adequately controlled studies are required to con-
firm whether academic detailing can reduce prescription
error rates in the Australian hospital setting. These should
include assessment of errors likely to impact on patient
outcomes.
A pre-intervention, post-intervention study in a Mel-
bourne teaching hospital examined an educational inter-
vention to reduce the use of "error-prone prescribing
abbreviations" in an emergency department (ED) [22].
The intervention, involving ED registrars and postgradu-
ate course nurses, included small group and one-to-one
tutorials about abbreviations commonly causing medica-
tion errors or confusion. Summary cards and posters rein-
forced this information. The intervention ran for six-
months. All medication and fluid charts in the ED depart-
ment were assessed for error-prone abbreviations at a ran-
domly selected time each day for one week before the
intervention and one week following. Abbreviations were
classified as being of major, moderate or minor signifi-
cance by two independent pharmacists. Charts for 166
patients were included in the two assessment phases. The
error-prone abbreviation rate per 100 prescriptions
decreased from 31.8 pre-intervention to 18.7 post-inter-
vention (p < 0.001). The rates of abbreviations classified
as of major significance decreased from 5.8 per 100 pre-
scriptions pre-intervention to 2.3 post-intervention (p <
0.001). The study was not controlled and the sustainabil-
ity of the effect over time is unknown.
The evidence for systems ensuring better dissemination of 
knowledge about drugs
Clinical decision support systems (CDSS) with computerised 
physician order entry (CPOE)
In the 2002 national patient safety report, careful imple-
mentation and evaluation of electronic prescribing with
decision support was suggested as a priority for improving
medication safety in Australia [2]. Implementation
research has since been conducted in Australia, however,
outcome studies are still lacking.
The limitations of using electronic prescribing alone are
highlighted in the findings of a 2001 study of discharge
prescriptions at a teaching hospital in Brisbane [23]. A
computer-generated discharge summary system enabled a
discharge prescription to be generated based on informa-
tion entered by the medical officer. An observational audit
of 200 discharge prescriptions was conducted; involving
100 handwritten prescriptions (605 medications) and
100 computer generated prescriptions (700 medications).
The same medical staff were responsible for both prescrip-
tion types. There were more errors in the computer gener-
ated prescriptions (81 errors, 11.6% of items) compared
to the handwritten ones (30 errors, 5.0% of items, p <
0.001). Errors judged to have the potential to result in
patient harm were similar between the groups. Errors that
occurred more frequently when a computer was used
included dosing errors (25 computer generated compared
with 5 handwritten errors) and duration of therapy errors
due to default settings in the computer. The authors con-
cluded that electronic prescribing without decision sup-
port and alerting systems could increase the risk of patient
harm.
Recognition that electronic medication management sys-
tems can introduce machine-related errors led a Univer-
sity of NSW research group to develop a multilevel
"accident model" to examine points in electronic prescrib-
ing systems where system failures may occur [24]. This
model used a systematic approach to identify human-
computer interaction processes as well as the context in
which electronic prescribing systems are used (such as
health professional cultures, organizational factors). The
aim is to aid the development of electronic prescribing
systems with features that improve patient safety. The
validity of the model is still to be tested.
Implementation of an inpatient electronic prescribing
and clinical decision support system in an acute and sub-Australia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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acute ward at a metropolitan and rural hospital in Victoria
found mixed results [25]. The system allowed a 'point and
click' method of prescribing for physicians' ordering inpa-
tient and discharge medications, integration with the hos-
pital's pharmacy ordering system and use of clinical
decision support tool. The clinical decision support
allowed checking of interactions, allergies and duplicate
ordering and access to drug information including the
AusDI drug and therapeutics database and MIMS. The sys-
tem was tested in one acute and one sub-acute 30-bed
ward within each hospital. In each ward two clinical com-
puters were available, in addition to a wireless laptop as a
point-of-care computer. Intensive training was provided
to medical officers and nursing staff. Use of the system in
the acute ward setting was discontinued after six weeks in
the rural hospital and eight weeks in the metropolitan
hospital. The barriers to effective implementation in the
acute ward setting were perceptions of increased clinical
risk, workload issues, lack of medical staff commitment,
insufficient computer access and technical and software
limitations (including inadequate interaction and allergy
checking, and problems with version control). The experi-
ence in the sub-acute ward setting in both hospitals was
different, with use becoming accepted practice and the
system being rolled out to other sub-acute wards. Medica-
tion error rates were not assessed. The study highlighted
the need for document control, understanding clinical
workflow issues and commitment through the whole
organization. One of the barriers in the acute care setting
was the need to frequently review medication charts and a
ban on handwritten alterations to charts. The authors con-
cluded that implementation of electronic prescribing and
clinical decision support systems requires a highly organ-
ised approach at all levels of the institution, giving consid-
eration to the technical and cultural issues and
environment in which it is to be used.
Another qualitative feasibility study for an 'electronic pre-
scribing decision support' (EPDS) system was undertaken
in a NSW public hospital [26]. The Sauer's Triangle of
Dependencies model was used to examine the organisa-
tional context in which an information system is placed.
The study used interviews and focus groups with medical
staff, pharmacists, nurse managers and clinical informa-
tion technology experts. Questions examined the limita-
tions of the present paper-based prescribing system,
technical requirements for an electronic prescribing and
decision support system, the environment in which the
system would be used, the political setting, the type of
ward structure suited to electronic prescribing, perceived
barriers to implementation and mechanisms for consult-
ing with medical staff in the design and implementation
of an information system. Only 9% of medical staff and
20% of nurse managers participated. Results found that
while nearly all participating clinicians indicated they
would be willing to adopt electronic prescribing and alert
systems, the implementation would be hampered by
existing barriers. Barriers included lack of confidence in
the security aspects of the system (e.g. use of electronic sig-
natures, failing to log-out of a system), lack of funding
and resources, concern about the time taken to complete
and check an electronic prescription (e.g. excessive drug-
drug interaction checking by some decision support/alert-
ing systems), lack of compatibility with the existing
patient administration system in the hospital and legisla-
tive barriers (such as legal requirement for handwritten
signatures). The majority of clinicians favoured the idea of
a state-wide EPDS system. Clinicians stated the need for
an integrated system that would overcome the need to log
into different systems for different types of results.
A 2007 project reviewed electronic medication manage-
ment (EMM) systems in the Australian setting [27]. A
multidisciplinary reference group including medical,
pharmacy and nursing representation as well as clinical
information technology experts formulated "key princi-
ples and core features" for assessing the suitability of an
EMM systems. Systems from 11 companies were evalu-
ated with all found to have the majority of the required
core functions seen as important by the reference group.
Systems were not ranked relative to each other. It con-
cluded that a number of available systems were suitable
for use in Australian hospitals, but that change manage-
ment issues needed to be addressed for implementation
to occur more widely.
The Australian Health Information Council (AHIC) pro-
vides advice to the Australian Health Ministers Advisory
Council (AHMAC) on information management and
technology in the health care system. A report by the
AHIC in 2008 [28] examined Electronic Decision Support
systems, with a focus on medicines, including the current
state of their implementation in Australia. This review
found there were some sound evidence-based programs
used in hospitals in some States. In Victoria, for example,
the Victorian Clinical Systems provided through Health
SMART  supported electronic prescribing and decision-
making by providing patient allergies, adverse reactions
and automatic checking for duplication and drug interac-
tions. However, the report highlighted that an agreed set
of national standards was lacking. The need to work with
professional bodies to examine possible barriers and
incentives for healthcare professionals in the uptake of
electronic decision support was identified, as was the need
for the health care workforce to be adequately supported
to gain the skills to use the technology [28].
Since the previous medication safety review [2], a number
of new studies have examined the implementation of elec-
tronic prescribing in combination with clinical decisionAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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support systems in Australian hospitals, but not the
impact on medication error or patient outcomes. The
potential value of these strategies now appears to be more
widely recognised by government, hospitals and health
professionals. Published studies provide useful insights
into some of the barriers to the introduction of this strat-
egy in the acute care setting that need to be considered
with wider implementation.
Evidence for systems promoting better medication 
distribution
Individual patient based medication distribution
In the 2002 review of medication safety in Australia [2],
individual patient medication supply systems were found
to reduce medication errors. Two Australian studies had
compared different medication distribution methods and
resultant errors associated with administration in the Aus-
tralian hospital setting [29,30], showing a decrease in
error rates. No further Australian studies were located. The
Society for Hospital Pharmacists of Australia Standards of
Practice for the Distribution of Medicines in Australian
Hospitals published in 2006 [31] state that unit-dose sys-
tems are the preferred method of medicines distribution
for healthcare facilities in terms of patient safety. How-
ever, there is a lack of published data on the uptake of
individual patient supply systems for medications in Aus-
tralian hospitals despite evidence supporting its use in
reducing medication errors.
Automated dispensing devices
Automated medication dispensing devices are electronic
storage devices that dispense medications in a controlled
manner and track the use of medication. The 2002 medi-
cation safety review [2] noted that evidence for automated
drug distribution systems in reducing medication inci-
dents was limited. Two studies that evaluated automated
drug distribution in the Australian health care setting
[32,33] did not provide clear evidence of the efficacy of
automated systems for reducing error. No further Austral-
ian studies since 2002 were located.
Evidence for systems ensuring adequate checking
Bar coding
In the previous review [2] there was international evi-
dence to support the investigation of bar coding as a strat-
egy to reduce medication error. Bar-coding or other
identification systems such as radio frequency identifica-
tion tags could allow medication packaging supplied for
an individual patient to be cross-checked with patient
identification information (such as a hospital patient
identification bracelet) at the point of medication admin-
istration [34]. Alternatively, more advanced systems could
allow electronic prescriptions to interface automated dis-
pensing systems to assemble individual medication packs
and track administration [34]. No published studies in
the Australian setting were identified.
An ongoing project administered by GS1 Australia (for-
merly EAN Australia) and the National E-Health Transi-
tion Authority (NEHTA) aims to implement an Australian
standard coding system for medicines - the Australian Cat-
alogue of Medicines (ACOM) [35]. This will ensure that
all prescription and non-prescription medicines (includ-
ing complementary medicines) have a globally unique
code. A national coding system is required to allow the
electronic transmission, storage and use of medication
information. This has the potential to facilitate the use of
bar coding technology.
Computer adverse drug event detection and alerts
A computer system may be used to detect potential
adverse drug events (such as interactions between differ-
ent medications, or abnormal laboratory results for a
patient taking a particular medication) and alert a
patient's health care professional such as physician or
pharmacist. The previous review [2] found limited inter-
national evidence but a lack of Australian research to sup-
port the use of such systems for improving medication
safety. No more recent Australian studies were located.
Single-person versus double-person checking by nurses administering 
medications
A study in a Victorian acute care hospital examined the
safety of single-checking by a registered nurse of medica-
tions that had required double-person checking [36].
These included medications requiring calculations, drugs
of addiction, cytotoxics, new drugs, epidurally adminis-
tered drugs, variable dose insulin, blood products and
high dose potassium chloride. Medication incident
reports were assessed in the single checking study for a
seven-month period and compared to those in the same
units in the same months of the previous year when dou-
ble-person checking was standard practice. There was no
significant difference between the two periods, however
the number of reported administration errors was low
(four in the study period and five in the previous year),
and the required study power to detect a difference was
not reported. This study analysed medication incidents
reported through the hospital's reporting scheme and did
not include any independent assessment of errors. Reli-
ance on incident reports may have meant errors were
undetected as incidents are known to be under-reported.
Further studies are required to provide conclusive evi-
dence about the relative safety of single and double-per-
son checking of high risk medications in the Australian
acute care setting.Australia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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Evidence for systems to improve medication 
administration
Drug packaging, storage and administration equipment
The potential for administration of IV medications by the
wrong route has been highlighted by cases of inadvertent
spinal administration of the anti-cancer medication vinc-
ristine [37]. The Society for Hospital Pharmacists of Aus-
tralia has recommended strategies to reduce the risk of
error associated with cytotoxic medications, with the abo-
lition of syringes for administration of vincristine in
favour of an infusion bag [37].
A system to prevent infusions being administered by the
incorrect route has been developed at the Women's and
Children's Hospital, Adelaide [38]. The system, called the
Adelaide Regional Connector (ARC), was under prototype
development in 2002. This colour coded luer incompati-
ble system ensures that syringes and other drug adminis-
tration equipment used to administer epidural and
intrathecal doses were not able to be connected to those
used to administer IV infusions.
Further research is needed to examine the current state of
implementation of system changes to reduce the risk of
inadvertent administration of IV and intrathecal medica-
tions by the wrong route.
Incorrect IV administration of potassium chloride can
potentially cause significant patient harm [39]. The Medi-
cation Safety Taskforce of the previous Safety and Quality
Council recommended components to be included in
guidelines for potassium chloride [40] and case studies
from two Australian hospitals were developed and made
available online.
A root cause analysis of an incident in which a bolus dose
of IV potassium chloride was inadvertently administered
at the Alfred hospital in Melbourne [41] led to the devel-
opment of pre-mixed solutions. These were developed by
physician consensus and in collaboration with the prod-
uct manufacturer. This allowed all concentrated potas-
sium chloride preparations to be removed from all
general wards. A policy for prescribing potassium chloride
in millimoles rather than grams was also implemented.
Outcomes were not evaluated.
Patient self-administration in the acute care setting
A pilot study in a Nursing Convalescent Unit of a large
metropolitan teaching hospital examined the effective-
ness of an inpatient self-medication program [42]. The
six-month study examined three levels of administration:
1) registered nurse (RN) administration; 2) patient medi-
cation with direct supervision from an RN; and 3) self-
medication with indirect RN supervision. Patient educa-
tion and a medication record card were key components
of the program. A total of 220 patients participated, with
45% remaining on Level 1, 26% reaching level 2 and 29%
reaching level 3. There were no patient initiated medica-
tion errors in the study period and two errors involving
staff, compared to one error in the previous six-month
period. This study was conducted in a specialized unit.
The findings, therefore, are not generalisable to other
acute care settings but warrant further investigation.
Education and training about medication administration errors
An orientation program for newly employed registered
nurses at a Queensland teaching hospital examined the
ability of nurses to identify medication errors and apply
strategies to prevent medication incidents [43]. The pro-
gram used simulated medication administration scenar-
ios of frequently occurring medication errors with
potential for harm. After each scenario the nurses were
asked whether they detected the errors, whether they
would have modified their practice and whether they were
aware of the error concept. Nurses were presented with
education about concepts of human error and risks, the
systems in place in the hospital to prevent medication
errors, roles and responsibilities in detecting errors and
preventing harm. The study was conducted over a two-
year period with 591 nurses participating. Results showed
that the risk would have been identified and appropriate
action taken in a median of 5 and average of 4 of the 6 sce-
narios. This study did not assess whether this translated
into improved recognition of medication errors in prac-
tice. Further research on the impact of education on inci-
dent rates and medication error detection in the acute care
setting is still needed.
Evidence for systems providing clinical pharmacy services
In the previous review [2] some Australian studies were
located which supported the role of clinical pharmacists
in improving patient safety. Newer studies, published
since 2002, further support this role.
A pre-test, post-test study examined the impact of an
emergency department (ED) clinical pharmacist on pre-
scribing errors in a Victorian metropolitan teaching hospi-
tal [44]. Prescription error rates for patients during a 5 day
control period were compared with error rates in the fol-
lowing week when a pharmacist ED service was provided.
In the intervention period a dedicated ED pharmacist
interviewed patients using a structured medication recon-
ciliation form to obtain a medication history and recon-
ciled the history with the ED medication chart where
possible or passed the information to the ward pharma-
cist. At 24 hours post-admission a senior clinical pharma-
cist reviewed the medication history and medication chart
and recorded and resolved any prescribing errors. Error
types were classified using an in-house classification sys-
tem and the risk rating was assessed by a blinded, inde-Australia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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pendent physician using standard risk assessment criteria.
There were 56 patients in the control period and 55 in the
intervention period with patient characteristics and the
number of drugs ordered per patient similar between
groups. There were 88 prescription errors detected in the
control period (1.6 errors/patient) and 25 in the interven-
tion period (0.5/patient) (p < 0.0001). There was a rela-
tive reduction of errors rated as high/extreme (64%
reduction), moderate (71% reduction) and minor (90%
reduction). This study supports the role of an ED pharma-
cist in reducing prescription errors, however further con-
trolled studies in other acute care hospitals in Australia are
needed to determine the generalisability of these findings.
Less rigorous evidence for the effectiveness of clinical
pharmacy interventions is provided by studies in which
interventions undertaken by clinical pharmacists have
been independently reviewed in order to assess their clin-
ical significance or impact on patient outcomes or medi-
cation error rates. A number of studies of this type have
been undertaken in the Australian setting as summarised
in the previous review [2]. The largest study conducted in
Australian acute care was published in 2004 [45]. Clinical
pharmacist interventions in eight major public hospitals
over an average of 21 days were reviewed by an independ-
ent multidisciplinary panel. There were 1,399 interven-
tions during 24,866 patient separations. Of these, 96
interventions (7%) were judged to have reduced the
patient's length of stay in hospital and 156 (11%) were
deemed to have reduced the potential for the patient to be
readmitted to hospital. The clinical significance of the
intervention was deemed to be life saving in 15 (1.1%),
major in 351 (25%), moderate in 535 (38%) and minor
in 425 (30%).
Evidence for systems improving information transfer
Information transfer at the hospital-community interface
In the previous review [2] it was noted that controlled
studies undertaken in Australia to assess the impact of dis-
charge medication management services implemented by
pharmacists or by pharmacists and nurses showed
improvements on patient outcomes and reductions in
undesirable medication events. Further research on this
type of service has been subsequently published.
A randomised, single blind, controlled trial conducted in
South Australia examined whether the addition of a phar-
macist transition coordinator could impact on medica-
tion management and health outcomes in older people
undergoing transition from a hospital to a long-term aged
care facility [46]. The study included 110 older adults dis-
charged from three metropolitan hospitals to long-term
care. The transition coordinator focused on the transfer of
medicines information to care providers in the long-term
care facility and the patient's family physician and com-
munity pharmacist. This included a medication transfer
summary (which supplemented normal discharge infor-
mation), coordination of a medication review by the
pharmacist contracted to the facility and a case conference
including the pharmacist coordinator, family physician,
community pharmacist and registered nurse from the
facility. The main outcome measure (the Medication
Appropriateness Index -MAI) was assessed at discharge
(baseline) and at 8 weeks post-discharge by independent
pharmacists blinded to patient group allocation. The MAI
was not significantly different between the groups at base-
line (intervention group 3.2 [95%CI 1.8-4.6]; control
group 3.7 [95% CI 2.2-5.2]), while at 8 weeks the MAI was
unchanged in the intervention group (2.5 [95%CI 1.4-
3.7]), but significantly higher (worse) in the control group
(6.5 [95% CI 3.9-9.1]). When patients who were alive at
the 8 week follow-up were included in the analysis, there
were significantly fewer hospital admissions and
unplanned emergency department attendances in the
intervention group (RR 0.38 [95% CI 0.15-0.99]). How-
ever, there was no significant difference if all patients were
included in the analysis. The intervention group reported
less "worsening pain" compared to the control group (RR
0.55 [95% CI 0.32-0.94]). No difference in adverse drug
events was detected (RR 1.05 [95% CI 0.66-1.68]). There
were no significant differences for falls, worsening mobil-
ity, worsening behaviour or increased confusion. This
study suggests a transition coordinator can improve
aspects of medication management during the transition
from hospital to residential aged care, however, no impact
on adverse drug events was demonstrated. This study is
limited by its small sample size and larger studies may be
required to determine whether the endpoints are sensitive
to this type of intervention.
Qualitative research has been published exploring the
potential role of a liaison pharmacist between hospital
and community health care settings in Australia [47]. This
study involved semi-structured interviews and a focus
group examining the discharge process, liaison between
hospital and community settings and the possible role of
a community liaison pharmacist. Participants included
medical practitioners, community nurses, community
pharmacists, hospital pharmacists, consumers and hospi-
tal administrators from a division of general practice in
Victoria. In general, participants felt that a community
liaison service should be targeted to those most a risk of
medication misadventure. Potential roles for the service
included providing advice and reassurance about medica-
tions, assessment of a patient's medication understanding
and ability to manage their medicines at home, education
and reinforcement of instructions about medicines and
communication of patient progress with service providers.
In general, domiciliary visits were considered the most
appropriate mechanism, however telephone calls wereAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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also suggested. The logistics of providing the service
included the need for domiciliary visits to be conducted
within one week of discharge, but preferably within 24-48
hours.
Other models for development of medication liaison serv-
ices between hospital and community settings have been
examined in major hospitals in NSW and South Australia.
In NSW a 'Heartlink' medication management pathway
for patients with chronic heart failure was developed
involving a community liaison pharmacist and medica-
tion management review facilitator [48]. On hospital
admission, patient consent was obtained for the hospital
pharmacist to communicate with the patient's preferred
community pharmacy to obtain a complete medication
history. The community pharmacist inserted an alert onto
the patient's computer file. On discharge from hospital
the patient was given a medication list by the hospital
pharmacist, and the community pharmacist was sent the
discharge prescription, information about medication
changes, any relevant information to assist long-term
patient monitoring and risk factors for medication misad-
venture. A community liaison pharmacist requested the
patient's GP refer the patient for a home medication
review (HMR) and provided the GP with information
about specific medication risk factors or recommenda-
tions from the hospital team. The liaison pharmacist
accompanied the accredited pharmacist on the HMR visit
to provide written resources and other information to the
patient. An HMR facilitator worked to provide informa-
tion to GPs and community pharmacists about the serv-
ice. A retrospective survey of GPs, community pharmacists
and accredited pharmacists found most agreed that the
service improved the link between the hospital and com-
munity setting. Time factors and lack of patient interest
was identified as the major barriers to the HMR process.
Patients receiving the service who responded to the ques-
tionnaire (n = 27) reported they were more confident tak-
ing medications regularly after the HMR and felt they
learnt something from the HMR (24 respondents, 89%).
In South Australia a pilot study examined a service from
within the hospital (before discharge) to organize an
HMR for patients at high risk of medication misadventure
[49]. Standard care involved mailing a discharge summary
to the patient's GP. The added service involved a liaison
pharmacist:
- sending a medication discharge summary to the
patient's GP and community pharmacist;
- organising an appointment for the patient with their
GP two days after discharge to order a HMR;
- requesting the community pharmacist arrange an
accredited pharmacist to undertake the HMR or order-
ing a hospital-funded review if the GP and community
pharmacist could not be involved;
- sending the HMR report to the hospital outpatient
clinic, the GP and community pharmacist.
Of the 50 eligible patients, 38 gave consent and 21
patients received the full service. The mean time for the
HMR was 18 ± 7 days post-discharge. Barriers to the serv-
ice included GP time constraints and unwillingness to
learn how to make an HMR referral. Community pharma-
cist barriers included time constraints and a lack of remu-
neration.
Information transfer between hospitals and general practitioners
An Australian study to promote medication information
transfer at the hospital community interface focused on
the transfer of information between general practitioners
and hospitals at both hospital admission and discharge
[50]. This quasi-pre-test post-test design study aimed to
improve communication between general practitioners
and hospital staff in an Area Health Service in NSW. Stage
one of the project [51], indicated that compliance with
the Australian Pharmaceutical Advisory Council (APAC)
National guidelines to achieve the continuum of quality use of
medicines between hospital and community was poor, and
that a number of barriers to effective communication
existed. A series of workshops were conducted which
identified changes that could be made to overcome these
communication barriers. In stage two, progress was
assessed using specific indicators. GPs (n = 122) com-
pleted questionnaires for two of their elderly patients dis-
charged from a hospital in the area health service.
Subsequently, a forum was held to review results and reas-
sess action plans. Three months later another survey was
conducted. In comparison with stage one, there were sub-
stantial and maintained improvements in faxing of dis-
charge summaries from hospitals to GPs (p < 0.001) and
provision of medication information to hospitals by GPs
for patients at risk (p < 0.05). Some problems, however,
had changed little including a poor rate of hospital notifi-
cation to GPs of a patient's admission to hospital. This
study did not use adverse drug events or medication error
as an outcome measure.
Shared electronic medication records
Initiatives to develop systems to improve the sharing of
medication information between patients and various
healthcare providers through a shared electronic medical
record have been funded through the Australian Govern-
ment. Since the last medication safety review [2] a Medi-
Connect program (formerly the Better Medication
Management System) began development. This programAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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aimed to develop a system to allow consumers to consent
to various different healthcare professionals accessing
and, where necessary, using and recording information in
a shared medication record. A secure national electronic
system was trialled successfully in two sites in Victoria and
Tasmania in 2003. In 2004 the MediConnect program
was incorporated within the wider HealthConnect pro-
gram [52]. HealthConnect is an ongoing partnership
between the Commonwealth and State and Territory Gov-
ernments to facilitate sharing of health information elec-
tronically. Systems for electronic sharing of patient health
information, including medication information between
different settings are currently under development and
evaluation in various states [53].
Medication record cards
The previous medication safety review [2] identified one
randomised controlled study in the hospital outpatient
setting which assessed the impact of using a medication
card in conjunction with medication counselling for
improving knowledge about medications and compliance
[54,55]. No further Australian studies were located.
Evidence for systems promoting multidisciplinary care
Medication Management Review and Case Conferencing Services
The only controlled Australian studies assessing medica-
tion management and case conferencing services have
been undertaken as part of hospital-community discharge
liaison studies [46,56-59]. No further studies in the acute
care setting in Australia were located.
Evidence for systems to promote reporting of medication 
incidents and adverse drug reactions
The previous medication safety review did not include
analysis of the evidence for improving adverse drug reac-
tion reporting or incident reporting [2], however it high-
lighted that routine data collection about undesirable
medication events is important for understanding why
medication incidents occur and how they might be pre-
vented. While there are well established mechanisms to
collect data on adverse drug reactions and medication
incidents in Australia, medication incidents and adverse
drug reactions are still under-recognised and under-
reported. Continued and increased participation needs to
be encouraged. Some strategies described in the recent lit-
erature have been developed to promote participation in
reporting.
A strategy to increase the reporting of adverse drug events
in the Alfred Hospital in Melbourne involved ensuring
medication errors identified via calls for the medical
emergency team (MET) were included in the hospital
quality programs [60]. The MET provides early interven-
tion when a patient's condition deteriorates and causes of
the deterioration are recorded. A modification of the MET
data management process involved including a category
on the reporting form for "adverse medication effect" and
a process to ensure that reports where medications were a
contributing factor were communicated monthly to the
pharmacy department. This allowed review and inclusion
in the hospital continuous quality improvement program.
The intervention enabled detection of adverse drug events
that would have been missed in the existing system.
Other studies have examined factors that influence
adverse drug reaction (ADR) reporting [61] and incident
reporting [62] in the acute care setting in Australia. Sug-
gested strategies to improve reporting included improving
the accessibility of report forms, encouraging computer-
based reporting and implementing educational initiatives
for nurses and junior medical staff [61]. In response to
barriers to incident reporting [62] suggestions included
development of time-efficient reporting systems and
resources to provide feedback and action in relation to
reported incidents and near-misses. Personal digital assist-
ants (PDAs) were successfully utilized by anaesthetists to
facilitate incident reporting [63]. There is a need for fur-
ther research in the Australian acute care setting to evalu-
ate whether these suggested strategies could increase
reporting rates.
Evidence for systems-based approaches to understanding 
and preventing medication errors
Systems to allow health services to assess medication systems and 
performance
The National Medication Safety Breakthrough Collabora-
tive was a key initiative of the former Australian Council
for Safety and Quality, which aimed to reduce harm from
medications. The collaborative of 100 health service
teams worked towards a goal of reducing medication-
related harm to patients by 50% [64]. Reported achieve-
ments included more than halving the percentage of
patients experiencing a high-risk adverse drug event (by
the top 8 hospital teams) and an increase in the percent-
age of hospitalised patients who had medicines informa-
tion communicated to their primary health care providers
in a timely manner - from less than 30% to over 90% (by
the top 8 hospital teams) [64]. The collaborative devel-
oped "toolkits" to improve medication safety, including
alert cards, incident report forms, education tools for staff
and patients, communication tools and guidelines for
high-risk medications [65,66].
The NSW Therapeutic Advisory Group (NSW TAG) and
the Clinical Excellence Commission have adapted
resources developed by the North American Institute for
Safe Medication Practices (ISMP). The "Medication Safety
Self Assessment for Australian Hospitals" and "Medication
Safety Self Assessment for Antithrombotic Therapy in Austral-
ian Hospitals" are available through the NSW GovernmentAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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Clinical Excellence Commission (CEC) website [67].
Completed assessments can be submitted to the CEC
through a secure site which provides a confidential online
report back to the hospital. The resources are designed to
allow hospital administrators, in conjunction with a
multidisciplinary team, to self assess their hospital's per-
formance on elements that have been shown to improve
safe use of medicines generally and anti-thrombotic
agents specifically. The system is currently used, but has
not been evaluated for its impact on improving medica-
tion safety [68].
System-based approaches to drug administration errors
A study conducted at a NSW tertiary hospital examined a
systems-based approach to reporting, review and feedback
of data obtained on prescribing incidents in the hospital
[69]. A database of prevented prescribing incidents (near-
miss incidents) detected by hospital pharmacists was
developed. A pharmacist classified incidents by type and
potential severity, and recorded descriptive data and a
brief narrative of the incident. Systems failures were iden-
tified from the data and fedback to specific clinical areas
and specialist medical officers. Clinical pharmacists spe-
cialising in the clinical area were involved in multidisci-
plinary forums with junior and senior medical officers in
which intervention reports were discussed. A survey was
sent to 21 senior clinicians who received reports through
the program, of which 10 (47%) responded. All indicated
that the feedback was of value in improving prescribing
practice and was incorporated into clinical quality pro-
grams. Most respondents (80%) indicated they found the
comparative data between departments useful.
A program to reduce the potential for medication infu-
sion-related error was undertaken at an acute care hospital
in Melbourne [70]. A multidisciplinary team examined
medication administration errors over a 29-month period
identifying root causes and contributing systems failures.
Identified systems failures included design flaws in tech-
nology currently in use, deviations from safe practice that
had become culturally accepted, complex and variable
medication prescribing, unnecessary administration prac-
tices, lack of accessible medication calculation resources
and limited accessible drug information. Improvement
initiatives included a medication safety education pro-
gram incorporating medication calculations initiatives, a
campaign to increase reporting of near-miss incidents,
strategies to address unsafe practices that had become
accepted in the hospital such as storing potassium chlo-
ride ampoules in bedside drawers with other medications
and poor labelling of drug infusions. Other initiatives
included the implementation of an auditing program,
changes to infusion pump equipment and methods to
standardize the prescribing and administration of particu-
lar medications. The impact of the program on medica-
tion infusion error rates in the hospital was not reported.
These studies describe initiatives to design system-based
approaches to reduce drug administration errors. There is
a need for further research in the Australian acute care set-
ting examining the actual impact of these approaches on
medication errors and adverse drug events.
Conclusion
In 2002, the former Australian Council for Safety and
Quality in Health Care, in its national report on medica-
tion safety, highlighted a number of systems solutions
known to be effective in improving medication safety [2].
These included clinical decision support systems; adverse
drug event alerts; systems that provide adequate checking,
such as bar coding; individual patient medication supply
systems; as well as provision of clinical pharmacy services
and discharge medication management services. Since
this review, further Australian studies addressing the evi-
dence base and experiences in their implementation have
now been published. However, gaps still exist.
There has been significant progress in strategies to
improve prescription writing for medications in hospitals
with the introduction of a NIMC now used in all Austral-
ian public hospitals and many private hospitals. Pub-
lished research has highlighted limitations with the chart,
however there are systems in place to allow ongoing eval-
uation and nationally coordinated strategies for making
changes to the chart design.
Studies have now assessed the implementation of compu-
terised prescribing and clinical decision support in Aus-
tralian hospitals, suggesting computerised prescribing
alone without decision support, may lead to increased
error. Studies have also highlighted that implementation
of these systems in acute care must include appropriate
education and training for staff, a change management
strategy and a highly organised approach at all levels of
the institution, giving consideration to the technical issues
and culture and environment in which it is to be used.
Similarly, the need for standardisation of systems and an
agreed set of national standards has been highlighted.
There remains a lack of published research on the impact
of electronic prescribing in combination with CDSS on
medication errors or adverse drug events when used by
health care practitioners in the acute care setting in Aus-
tralia.
New strategies that have been assessed include double
checking versus single checking by nurses for safe medica-
tion administration and patient self-administration in
hospital. The small studies found no significant differ-
ences between groups, however, the studies were onlyAustralia and New Zealand Health Policy 2009, 6:24 http://www.anzhealthpolicy.com/content/6/1/24
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located in single centres and possibly had insufficient
power to detect differences. While these studies do not
provide sound evidence of effectiveness, they warrant fur-
ther research in these areas.
Other strategies that have been implemented but the
impact on medication error rates not reported include
leur incompatible systems to avoid incorrect route of
administration for intravenous and intrathecal injections,
as well as the removal of concentrated potassium chloride
from wards with replacement by pre-mixed solutions.
Academic detailing has been demonstrated to reduce
errors in prescriptions for Schedule 8 medicines where
error rates were high and an uncontrolled study suggested
an education program was effective in reducing the use of
error prone prescribing abbreviations in the emergency
department setting.
Studies have continued to assess hospital discharge plan-
ning or liaison pharmacy services primarily focusing on
implementation issues. Barriers to home medication
reviews after hospital discharge include workload factors
for both general practitioners and pharmacists and lack of
patient interest, as well as the ability to engage an accred-
ited pharmacist in a timely manner. One new model
included a transition co-ordinator to assist transfer of
medication information for patients discharged from hos-
pital to residential aged-care facilities. The model demon-
strated an improvement in medication appropriateness,
however there was no significant impact on adverse drug
events, but the study may have had insufficient power to
detect this endpoint.
No new studies were located that have assessed the impact
of individual patient medication supply, adverse drug
event alerts or bar coding. The extent of their implemen-
tation across Australia is unknown.
While there is now a stronger evidence base demonstrat-
ing that systems factors are major contributors to medica-
tion errors, there is still very limited research assessing the
impact of an integrated set of activities on medication
safety.
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